Skip to main content

Relapsing-Remitting Multiple Sclerosis (MS) Market Growth Analysis by Diagnostic, Evolving Technologies and Trends

The Global “Relapsing-Remitting Multiple Sclerosis (MS) Market is expected to register a CAGR of 3.1% during the forecast period of 2019 to 2025” and held a value of USD 4,976 million in 2018.
Market Overview
Relapsing-Remitting Multiple Sclerosis Market is characterized by attacks of new or increasing neurologic symptoms. These attacks are also called relapses or exacerbations and are followed by periods of partial or complete recovery. Approximately 85% of people with MS are initially diagnosed with relapsing remitting MS.
The growth of the global Relapsing-Remitting Multiple Sclerosis Market is boosted by various factors such as rising research in the multiple sclerosis treatment fields and increasing innovations by significant players. However, the stringent regulations and high cost of drugs are likely to curb the growth of the global relapsing-remitting MS market.
Market Segmentation
The global Relapsing-Remitting Multiple Sclerosis Market has been segmented based on treatment, route of administration, and end user.
based on treatment, has been divided into immunomodulating drugs, Nrf2 activators, interferons, and others. The immunomodulating drugs segment is likely to be the largest during the review period due to the growing advantages of this drug type in comparison to others. The Nrf2 activators segment is predicted to be the fastest-growing due to the increasing awareness and research in the market.
based on the route of administration, into oral and intravenous. The oral segment is expected to hold the majority share of the market owing to the increasing efficiency rates of this mechanism. The intravenous segment is expected to be the fastest-growing due to the increased awareness about this route of administration.
The end users of the market are hospitals, clinics, and others. The hospitals segment is expected to hold the largest share of the market due to the increasing number of hospitals. The clinics segment is expected to be the fastest growing owing to the increased preference of medical professionals.
Major Market Key Players
Several market players currently dominate the global relapsing-remitting MS market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
Some of the key players in the global Competitive market are –
Glenmark Pharmaceuticals (India)
Eisai Co.Ltd (Japan)
Biogen (US)
Merck KGaA (US)
Sanofi Genzyme (US)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd (Israel).
Market Drivers
  • Increasing research initiatives
  • Rising need for treatment of relapsing-remitting MS
  • High prevalence of MS
  • Increasing product launches
  • Growing awareness regarding the severity of this form of MS
Regional Analysis
The Relapsing-Remitting Multiple Sclerosis Market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the upcoming research activities by key players. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing pool of patient population suffering from relapsing-remitting MS, the market in Asia-Pacific is expected to be the fastest-growing. The Market in the Middle East & Africa has been divided into the Middle East and Africa.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...
Post a Comment
Read more